Docetero RTU Injection (Docetaxel Injection IP 20 mg)

Docetero RTU Injection is a branded oncology injectable containing docetaxel, a semi-synthetic taxane anticancer agent. Formulated using Ready-to-Use (RTU) technology, this product is designed to simplify preparation within regulated oncology treatment settings. Docetero RTU Injection with Docetaxel Injection IP 20 mg is supplied by AmeriDrugs strictly for export to licensed pharmaceutical importers, distributors, hospitals, and pharmacies operating within approved regulatory frameworks.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Docetaxel IP

• Strength: 20 mg per 1 ml

• Pharmaceutical Form: Sterile injectable solution

Therapeutic Use (Informational, Non-Advisory)
Docetaxel is a taxane-class antineoplastic agent used in approved oncology protocols for the management of various solid tumors. Docetero RTU Injection is utilized within regulated healthcare environments as part of combination chemotherapy regimens determined by institutional guidelines and regulatory approvals. This information is provided solely for product identification and regulatory clarity and does not constitute medical advice or treatment recommendations.

Dosage Form & Route of Administration

• Dosage Form: Ready-to-use injectable solution

• Route of Administration: Intravenous infusion after dilution

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical and oncology settings

Quality & Manufacturing Standards
Docetero RTU Injection is manufactured in compliance with current Good Manufacturing Practices (GMP) and pharmacopeial quality standards. RTU formulation technology is employed to ensure consistency, sterility, and stability. Each production batch undergoes comprehensive quality control testing to meet international export and regulatory requirements.

Packaging Information (Export-Oriented)

• Primary Packaging: Glass vial containing 1 ml sterile solution

• Secondary Packaging: Printed carton with compliant labeling

• Packaging optimized for oncology supply chains and international logistics

• Export documentation and market-specific labeling support available

Target Buyers

• Licensed pharmaceutical importers and distributors

• Oncology hospitals and specialty cancer centers

• Retail and wholesale pharmacies under prescription regulation

• Government and private institutional procurement agencies

• International distributors specializing in oncology injectables

Regulatory & Compliance Note
Docetero RTU Injection is a prescription-only oncology medicine intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Supply is subject to import authorization, local drug regulatory approvals, and institutional procurement policies in the destination country. AmeriDrugs follows international export compliance standards and documentation protocols.